Saturday 17 October 2026 Export AMPH’s income statement to Excel — free account

Amphastar Pharmaceuticals, Inc.

AMPH Healthcare Drug Manufacturers Specialty & Generic

Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.

25.87 0.55 −2.08%

Follow AMPH

Alert me

Market cap: $1.1B
P/E: 14.9×
Fwd P/E: 14.7×
Dividend yield: —
F-score: 6/9
Altman Z: 2.54
Beneish M: −2.57
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	10.30%	10.39%	12.90%	14.84%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	6	6	5
ROA Full definition →	4.68%	4.84%	6.12%	6.95%
ROIC Full definition →	6.57%	6.69%	7.88%	8.46%
Return on Tangible Assets Full definition →	11.49%	10.20%	12.44%	15.03%
Average Days of Receivables Full definition →	73.74	79.76	81.49	75.13
Free Cash Flow per Share Full definition →	3.50	2.98	2.54	2.39
Free Cash Flow Full definition →	152.89	135.19	118.83	110.85
Capital Expenditures Full definition →	(31.72)	(33.69)	(37.28)	(41.42)
Other line items
Cash ROIC Full definition →	9.14%	8.05%	7.05%	6.66%
Accounts Receivable Turnover Full definition →	5.18	4.76	4.82	4.92
Accounts Payable Turnover Full definition →	1.83	2.31	2.38	2.13
Inventory Turnover Full definition →	2.06	2.13	2.20	2.32
Average Days of Payables Full definition →	240.24	146.89	148.83	190.18
Days of Inventory on Hand Full definition →	171.94	163.73	177.46	185.29
Tax Rate Full definition →	(0.23)	(0.23)	(0.21)	(0.18)
Research and Development Expense of Revenue Full definition →	12.95%	12.84%	11.92%	11.15%
Selling, General and Administrative Expense of Revenue Full definition →	19.08%	18.31%	18.03%	17.48%
Share Based Compensation of Revenue Full definition →	3.95%	3.91%	3.79%	3.69%
Interest Coverage Full definition →	4.37	4.53	5.51	5.93
Operating CF/Net income Full definition →	2.35	2.13	1.59	1.36
Depreciation/Fixed assets Full definition →	0.19	0.20	0.19	0.19
Capex/Depreciation Full definition →	(0.52)	(0.55)	(0.62)	(0.70)
Revenue per Share Full definition →	16.73	15.90	15.40	15.56
Operating CF per Share Full definition →	4.23	3.73	3.34	3.28
Capex per Share Full definition →	(0.73)	(0.74)	(0.80)	(0.89)
Capex to Sales Full definition →	0.04	0.05	0.05	0.06

Show all line items

Columns are period end dates

Stockrow Weekly